Monitoring the dynamics of B-natriuretic paptide may have a major impact on the choice of treatment of the patient with heart failure;Sledování dynamiky B-natriuretického peptidu může zásadně ovlivnit volbu léčebného postupu u pacienta se srdečním selháním

Cor et Vasa

Volumn 51, Issue 1, 2009, Pages 45-48

  Málek, Ivan ^a   Hegarová, Markéta ^a   Lupínek, Petr ^a   Tintěra, Jaroslav ^b  

^a Klinika Kardiologie   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

B natriuretic peptide; Heart failure; Spongiform cardiomyopathy

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CLINICAL DECISION MAKING; CONSERVATIVE TREATMENT; DISEASE COURSE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SPONGIFORM CARDIOMYOPATHY;

EID: 59149092520     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2009.012     Document Type: Article

References (8)

1. Špinar J, Hradec J, Meluzín J, a spol. Doporučení pro diagnostiku a léčbu chronického srdečního selhání ČKS 2006. Cor Vasa 2007;49:K5-K34.
2. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). The task force for the diagnosis and treatment of CHF of the European Society of Cardiology. Eur Heart J 2005;26:1115-40.
3. Oechslin EN, Attenhofer JCH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500.
4. Troughton RW, Frampton ChM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (BNP) concentrations. Lancet 2000;355:1126-30.
5. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. JACC 2007;49:1733-9.
6. Shah MR, Califf RM, Nohria A, et al. STARBRITE: a randomized pilot trial of BNP-guided therapy in patients with advanced heart failure. Paper presented at: American Heart Association Scientific Sessions; November 12-15, 2006, Chicago, IL.
7. Lainchbury JG, Troughton RW, Frampton CM, et al. NT-proBNP guided drug treatment for chronic heart failure: design and methods in the BATTLE-SCARRED trial. Eur J Heart Fail 2006;8:532-8.
8. Brunner-La-Rocca HP, Buser PT, Schindler R, et al. Management of elderly patients with congestive heart failure - Design of the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Am Heart J 2006;151:949-55.